Unraveling the role of host kinase PIM1 in Toxoplasma gondii infection: Implications for therapies
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0013915 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Lijie Pan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Parasitology, Anhui Province Laboratory of Zoonoses, School of Basic Medical Sciences, Anhui Medical University, Hefei…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-pim-1, Toxoplasma, Toxoplasmosis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific Research Foundation of Education Department of Anhui Province of China, Anhui Medical University Doctoral Scientific Research Foundation.
Abstract (Originalsprache)
Toxoplasma gondii , a widespread intracellular protozoan parasite, infects a significant portion of the global human population. Restricted to an acute-infection model, this study elucidates the role of the host protein PIM1, a serine/threonine protein kinase, in facilitating T. gondii proliferation and its potential as a therapeutic target. Employing both in vitro and in vivo models, we establish that PIM1 enhances the intracellular proliferation of T. gondii by suppressing host cell apoptosis. Our findings underscore the necessity of PIM1’s kinase activity in this process, as evidenced by the significant reduction in T. gondii proliferation upon treatment with either a kinase-dead PIM1 mutant or the PIM1 inhibitor AZD1208. In murine models, AZD1208 treatment resulted in decreased T. gondii load and elevated pro-apoptotic markers in tissues, indicating that PIM1 inhibition bolsters the host’s immune response against the parasite. Since the role of PIM1 in chronic infection remains unexplored, follow-up studies using chronic models are essential. Collectively, our findings illuminate host–parasite interplay during acute toxoplasmosis and position PIM1 as a promising target for anti- T. gondii therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Parasitology, Anhui Province Laboratory of Zoonoses, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, China.
- Clinical College of Anhui Medical University, Hefei, Anhui, China.
- Hefei First People's Hospital, the Third Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Yuanyuan Cao
Förderung
- National Natural Science Foundation of China
- Scientific Research Foundation of Education Department of Anhui Province of China
- Anhui Medical University Doctoral Scientific Research Foundation
- National Key Laboratory of Pathogen Microbiology Biosafety Open Fund Project
- Anhui Provincial Key Laboratory of Pathogen Biology Open Fund Project
Zitieren
APA
Pan, L., Zhang, F., Yang, Y., Sun, Y., Song, L., Zhang, F., Zhu, J., Wang, Y., Wang, C., Luo, Q., Zhang, W., Yu, L., & Cao, Y. (2026). Unraveling the role of host kinase PIM1 in Toxoplasma gondii infection: Implications for therapies. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013915
Vancouver
Pan L, Zhang F, Yang Y, Sun Y, Song L, Zhang F, et al. Unraveling the role of host kinase PIM1 in Toxoplasma gondii infection: Implications for therapies. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0013915
BibTeX
@article{Pan2026,
author = {Pan, Lijie and Zhang, Fan and Yang, Yun and Sun, Yue and Song, Lingling and Zhang, Famin and Zhu, Jinjin and Wang, Yang and Wang, Chong and Luo, Qingli and Zhang, Wen and Yu, Li and Cao, Yuanyuan},
title = {Unraveling the role of host kinase PIM1 in Toxoplasma gondii infection: Implications for therapies},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0013915}
}
EUVIMED